BioVie Statistics
Total Valuation
BioVie has a market cap or net worth of $11.27 million. The enterprise value is -$13.34 million.
Important Dates
The last earnings date was Monday, November 10, 2025, after market close.
| Earnings Date | Nov 10, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BioVie has 7.54 million shares outstanding. The number of shares has increased by 404.04% in one year.
| Current Share Class | 7.54M |
| Shares Outstanding | 7.54M |
| Shares Change (YoY) | +404.04% |
| Shares Change (QoQ) | +180.58% |
| Owned by Insiders (%) | 0.53% |
| Owned by Institutions (%) | 16.00% |
| Float | 7.50M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.44 |
| P/TBV Ratio | 0.46 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 15.83, with a Debt / Equity ratio of 0.01.
| Current Ratio | 15.83 |
| Quick Ratio | 15.30 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -244.38 |
Financial Efficiency
Return on equity (ROE) is -94.79% and return on invested capital (ROIC) is -55.85%.
| Return on Equity (ROE) | -94.79% |
| Return on Assets (ROA) | -50.01% |
| Return on Invested Capital (ROIC) | -55.85% |
| Return on Capital Employed (ROCE) | -76.38% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.43M |
| Employee Count | 13 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -95.18% in the last 52 weeks. The beta is 0.52, so BioVie's price volatility has been lower than the market average.
| Beta (5Y) | 0.52 |
| 52-Week Price Change | -95.18% |
| 50-Day Moving Average | 1.71 |
| 200-Day Moving Average | 6.48 |
| Relative Strength Index (RSI) | 46.22 |
| Average Volume (20 Days) | 70,693 |
Short Selling Information
The latest short interest is 174,314, so 2.31% of the outstanding shares have been sold short.
| Short Interest | 174,314 |
| Short Previous Month | 213,035 |
| Short % of Shares Out | 2.31% |
| Short % of Float | 2.32% |
| Short Ratio (days to cover) | 1.38 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -19.23M |
| Pretax Income | -18.48M |
| Net Income | -18.57M |
| EBITDA | -19.00M |
| EBIT | -19.23M |
| Earnings Per Share (EPS) | -$7.08 |
Full Income StatementBalance Sheet
The company has $24.98 million in cash and $332,730 in debt, giving a net cash position of $24.65 million or $3.27 per share.
| Cash & Cash Equivalents | 24.98M |
| Total Debt | 332,730 |
| Net Cash | 24.65M |
| Net Cash Per Share | $3.27 |
| Equity (Book Value) | 24.92M |
| Book Value Per Share | 3.31 |
| Working Capital | 24.39M |
Full Balance SheetCash Flow
| Operating Cash Flow | -18.47M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
